Coronavirus disease 2019 and mRNA vaccines: what's next - miRNA?
作者信息
Lee Joon Kee, Han Heon-Seok
机构信息
Department of Pediatrics, Chungbuk National University Hospital, Cheongju, Korea.
Department of Pediatrics, Chungbuk National University College of Medicine, Cheongju, Korea.
出版信息
Clin Exp Pediatr. 2022 Jun;65(6):302-303. doi: 10.3345/cep.2022.00283. Epub 2022 Mar 28.
Abstract
摘要
相似文献
1
Coronavirus disease 2019 and mRNA vaccines: what's next - miRNA?2019冠状病毒病与mRNA疫苗：接下来是什么——微小RNA？
Clin Exp Pediatr. 2022 Jun;65(6):302-303. doi: 10.3345/cep.2022.00283. Epub 2022 Mar 28.
2
COVID-19 Vaccines Have Been Available in the US for More Than a Year-What's Been Learned and What's Next?新冠疫苗在美国已可用一年多了——我们了解到了什么，接下来又会怎样？
JAMA. 2022 Feb 8;327(6):513-516. doi: 10.1001/jama.2022.0106.
3
mRNA COVID vaccines saved lives and won a Nobel - what's next for the technology?信使核糖核酸新冠疫苗拯救了生命并赢得了诺贝尔奖——这项技术的下一步是什么？
Nature. 2023 Oct 3. doi: 10.1038/d41586-023-03119-x.
4
Binge eating disorder revisited: what's new, what's different, what's next - Addendum.暴饮暴食症再探讨：新变化、差异及未来走向——附录
CNS Spectr. 2019 Aug;24(S1):82. doi: 10.1017/S1092852919001366.
5
Coronavirus outbreak: what's next?冠状病毒爆发：接下来会怎样？
Nature. 2020 Feb;578(7793):15-16. doi: 10.1038/d41586-020-00236-9.
6
Dental software: what's hot, what's not, what's next.牙科软件：热门、冷门与未来走向
Dent Today. 2000 Apr;19(4):102, 104.
7
COVID-19: WHAT'S NEXT?新冠疫情：接下来会怎样？
Rev Invest Clin. 2021;73(5):329-334. doi: 10.24875/RIC.21000362.
8
Kynurenine Pathway in Chronic Kidney Disease: What's Old, What's New, and What's Next?慢性肾脏病中的犬尿氨酸途径：旧知、新知与未来？
Int J Tryptophan Res. 2020 Sep 21;13:1178646920954882. doi: 10.1177/1178646920954882. eCollection 2020.
9
The Wuhan SARS-CoV-2-What's next for China.武汉的新冠病毒——中国的下一步是什么。
J Med Virol. 2020 Jun;92(6):546-547. doi: 10.1002/jmv.25738. Epub 2020 Mar 18.
10
SARS, MERS, and COVID-19: What's next?非典、中东呼吸综合征和新型冠状病毒肺炎：接下来会怎样？
Int J Surg. 2020 Dec;84:66-68. doi: 10.1016/j.ijsu.2020.10.020. Epub 2020 Oct 24.
引用本文的文献
1
MicroRNAs in the development of potential therapeutic targets against COVID-19: A narrative review.微小 RNA 在开发针对 COVID-19 的潜在治疗靶点中的作用：叙事性综述。
J Infect Public Health. 2022 Jul;15(7):788-799. doi: 10.1016/j.jiph.2022.06.012. Epub 2022 Jun 21.
本文引用的文献
1
Implication of microRNA as a potential biomarker of myocarditis.微小RNA作为心肌炎潜在生物标志物的意义。
Clin Exp Pediatr. 2022 May;65(5):230-238. doi: 10.3345/cep.2021.01802. Epub 2022 Mar 2.
2
Risk Factors for Severe COVID-19 in Children: A Systematic Review and Meta-Analysis.儿童重症 COVID-19 的危险因素：系统评价和荟萃分析。
J Korean Med Sci. 2022 Feb 7;37(5):e35. doi: 10.3346/jkms.2022.37.e35.
3
Clinically Suspected Myocarditis Temporally Related to COVID-19 Vaccination in Adolescents and Young Adults: Suspected Myocarditis After COVID-19 Vaccination.青少年和青年中临床上疑似与新冠病毒疫苗接种存在时间关联的心肌炎：新冠病毒疫苗接种后疑似心肌炎
Circulation. 2022 Feb;145(5):345-356. doi: 10.1161/CIRCULATIONAHA.121.056583. Epub 2021 Dec 6.
4
SARS-CoV-2 vaccines in development.正在研发中的 SARS-CoV-2 疫苗。
Nature. 2020 Oct;586(7830):516-527. doi: 10.1038/s41586-020-2798-3. Epub 2020 Sep 23.
5
Metazoan MicroRNAs.后生动物 MicroRNAs。
Cell. 2018 Mar 22;173(1):20-51. doi: 10.1016/j.cell.2018.03.006.
6
Contemporary Postnatal Incidence of Acquiring Acute Myocarditis by Age 15 Years and the Outcomes From a Nationwide Birth Cohort.15 岁以下儿童后天获得急性心肌炎的当代发病率及其全国性出生队列研究结果。
Pediatr Crit Care Med. 2017 Dec;18(12):1153-1158. doi: 10.1097/PCC.0000000000001363.
7
Characteristics of Clinically Diagnosed Pediatric Myocarditis in a Contemporary Multi-Center Cohort.当代多中心队列中临床诊断的小儿心肌炎的特征
Pediatr Cardiol. 2017 Aug;38(6):1175-1182. doi: 10.1007/s00246-017-1638-1. Epub 2017 May 23.
8
microRNA and Chronic Lymphocytic Leukemia.微小RNA与慢性淋巴细胞白血病
Adv Exp Med Biol. 2015;889:23-40. doi: 10.1007/978-3-319-23730-5_2.
9
Diagnosis and treatment of myocarditis in children in the current era.当代儿童心肌炎的诊断与治疗
Circulation. 2014 Jan 7;129(1):115-28. doi: 10.1161/CIRCULATIONAHA.113.001372.
10
MicroRNA expression profiling using microarrays.使用微阵列进行微小RNA表达谱分析。
Nat Protoc. 2008;3(4):563-78. doi: 10.1038/nprot.2008.14.
Zotero 插件